Scientist to Watch

» ecology, evolution, cancer and behavior

Most Recent

image: Angela Brooks: Splicing Specialist

Angela Brooks: Splicing Specialist

By | April 1, 2017

At the University of California, Santa Cruz, the researcher combs the cancer genome, looking for weaknesses.

0 Comments

image: Jeremy Day Probes Reward Signaling in the Brain

Jeremy Day Probes Reward Signaling in the Brain

By | January 1, 2017

The University of Alabama, Birmingham, researcher seeks the neural roots of animal behavior

0 Comments

Member, Department of Immunology, St. Jude Children’s Research Hospital. Age: 43

0 Comments

Instructor, Department of Systems Biology, University of Texas MD Anderson Cancer Center. Age: 38

1 Comment

image: Jason Holliday: Tree Tracker

Jason Holliday: Tree Tracker

By | February 1, 2016

Associate Professor, Virginia Tech, Department of Forest Resources and Environmental Conservation. Age: 37

0 Comments

image: Yoav Gilad: Gene Regulator

Yoav Gilad: Gene Regulator

By | October 1, 2013

Professor, Department of Human Genetics, University of Chicago. Age: 38

3 Comments

image: Mary O’Connor: Warming Up

Mary O’Connor: Warming Up

By | June 1, 2013

Assistant Professor, Department of Zoology, University of British Columbia. Age: 34

1 Comment

image: Megan Carey: Cerebellum Prober

Megan Carey: Cerebellum Prober

By | August 1, 2012

Group Leader, Neuroscience Program, Champalimaud Center for the Unknown, Lisbon, Portugal; HHMI International Early Career Scientist; Age: 38

0 Comments

image: David Sabatini: Demystifying mTOR

David Sabatini: Demystifying mTOR

By | March 1, 2012

Principal Investigator, Whitehead Institute for Biomedical Research. Associate Professor, Department of Biology, Massachusetts Institute of Technology. Age: 44

0 Comments

image: Lynne-Marie Postovit: Cancer Modeler

Lynne-Marie Postovit: Cancer Modeler

By | January 1, 2012

Assistant Professor, Department of Anatomy and Cell Biology, University of Western Ontario. Age: 34

3 Comments

Popular Now

  1. Consilience, Episode 3: Cancer, Obscured
  2. RNAi’s Future in Drug-Target Screening
    News Analysis RNAi’s Future in Drug-Target Screening

    A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

  3. A History of Screening for Natural Products to Fight Cancer
  4. Human Cord Plasma Protein Boosts Cognitive Function in Older Mice
AAAS